Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Johnathan Man"'
Publikováno v:
JNCI Cancer Spectrum
Background Expression of programmed cell death ligand 1 (PD-L1) on tumor cells with or without immune cells is widely reported in clinical trials of programmed cell death receptor 1 (PD-1) blockade in metastatic non-small cell lung cancer. Various cu
Publikováno v:
Asia-Pacific Journal of Clinical Oncology. 14:141-152
Background: We performed a meta‐analysis to quantify toxic death, adverse events (AEs) and treatment discontinuation due to AEs from checkpoint inhibitors (CI). Methods: We searched for randomized trials with adequate reporting for toxicity outcome
Autor:
John Simes, Sarah J. Lord, Felicia T. Roncolato, Johnathan Man, Doah Cho, Matthew Links, Chee Khoon Lee
Publikováno v:
JCO Precision Oncology. :1-12
Purpose The demand for more rapid access to novel biologic therapies than randomized controlled trials can deliver is a topic of ongoing study and debate. We aimed to inform this debate by estimating therapeutic success from phase III trials comparin
Autor:
Hung, Johnathan Man Chiu
The $\Lambda$CDM model for the Universe is highly successful in explaining cosmological observations to date, and its parameters tightly constrained by Cosmic Microwave Background (CMB) experiments such as Planck. Higher-order statistics, like the th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9dd2bd50cb910dbeb2039e3e4b4beae0
Autor:
Alison Lyon, Kahren M. White, Dan Ewald, Nicola Creighton, David C. Currow, Chee Khoon Lee, David Michail, Deborah Baker, Lawrence Tan, Andrew Miller, Johnathan Man, Jane M. Young, Stuart Purdie
Publikováno v:
NPJ Primary Care Respiratory Medicine
npj Primary Care Respiratory Medicine, Vol 29, Iss 1, Pp 1-6 (2019)
npj Primary Care Respiratory Medicine, Vol 29, Iss 1, Pp 1-6 (2019)
Little has been published on the diagnostic and referral pathway for lung cancer in Australia. This study set out to quantify general practitioner (GP) and lung specialist attendance and diagnostic imaging in the lead-up to a diagnosis of non-small c
Autor:
Benjamin C. H. Kwan, Saidul Ansary, Johnathan Man, Jason Behary, John Riskallah, Shahila Aslam
Publikováno v:
Open Journal of Respiratory Diseases. :52-57
Multidisciplinary community coordinated care programs are widely adopted to optimise care of chronic disease patients, but there is a need for further evaluation in the setting of COPD. This observational study evaluated 147 patients with severe or v
Autor:
Georgia Ritchie, Johnathan Man, Ian C. Marschner, Michael Friedlander, Sarah J. Lord, Harry Gasper, Chee Khoon Lee
Publikováno v:
JAMA oncology. 4(4)
Importance Checkpoint inhibitors have a unique mechanism of action that differs from chemotherapy or targeted therapies. The validity of objective response rate (ORR) as a surrogate for progression-free survival (PFS) and overall survival (OS) in che
Autor:
Wendy A Cooper, Matthew Links, Val Gebski, Richard J. Gralla, Chee Khoon Lee, Tony Mok, Johnathan Man, Sarah J. Lord, Roy S. Herbst, James Chih-Hsin Yang
Checkpoint inhibitors have replaced docetaxel as the new standard second-line therapy in advanced non-small cell lung carcinoma (NSCLC), but little is known about the potential predictive value of clinical and molecular characteristics.To estimate th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::936f07c9af35b43fb15013c7c0108535
https://europepmc.org/articles/PMC5838598/
https://europepmc.org/articles/PMC5838598/
Publikováno v:
Asia-Pacific Journal of Clinical Oncology. 15:191-191
We thank the reviewers for bringing this error in methods to our attention. We appreciate that double counting of participants in the control arm of trials with multiple intervention arms is not recommended. We have re‐analyzed our data and found v
Publikováno v:
Journal of Thoracic Oncology. 12:S2002-S2003